Parvovirus B19 in pregnancy: baby outcomes
Part of Infections, Skin clinical trials.
This study looks at pregnant women with parvovirus B19 infection and follows what happens with the baby, including any health issues after birth. It helps doctors understand how the infection affects pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and over 18 years old.
- You have been diagnosed with parvovirus B19 infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of treating hepatitis B in pregnant women to prevent passing the virus to their babies. It tests whether a standard universal treatment approach works better than a quick, point-of-care test-based strategy.
This study looks at pregnancies that are considered high-risk because the baby is affected by a difference found during pregnancy or at birth. It may help researchers understand and improve care for families dealing with these fetal (baby) anomalies.
This study looks at how the immune system responds to a first-time cytomegalovirus (CMV) infection during pregnancy. The goal is to find better ways to predict if the virus will pass to the baby.
This study follows pregnant women with a viral infection (like COVID-19, HIV, or hepatitis) and their children to learn how the infection affects both. It helps doctors better understand and care for families during and after pregnancy.
This study follows pregnant women and their babies to learn more about COVID-19 and how it affects them. By taking part, you help researchers understand the virus and improve care for mothers and children.
This study looks at how COVID-19 and COVID vaccination during pregnancy may affect mothers and newborns. Your team will collect health information around delivery to understand what outcomes are most common.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.